Haemophilia A in two premature infants

European Journal of Pediatrics

Volumn 164, Issue 2, 2005, Pages 70-72

  Bidlingmaier, Christoph ^a   Bergmann, Frauke ^b   Kurnik, Karin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MVZ Wagnerstibbe   (Germany)

Author keywords

Factor VIII replacement therapy; Haemophilia; Neonate; Prematurity

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD DERIVATIVE; BLOOD SUBSTITUTE; INDOMETACIN; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTICLE; BLEEDING; BLOOD ANALYSIS; BLOOD SUBSTITUTION; BRAIN HEMORRHAGE; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CAUSE OF DEATH; DISEASE COURSE; DISEASE SEVERITY; DRUG HALF LIFE; GESTATIONAL AGE; HEART SURGERY; HEMOPHILIA A; HUMAN; INFANT; LABORATORY TEST; MALE; MENTAL DEFICIENCY; NEWBORN; PATENT DUCTUS ARTERIOSUS; PLASMA VOLUME; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT INDICATION; TREATMENT OUTCOME;

DRUG ADMINISTRATION SCHEDULE; FACTOR VIII; HALF-LIFE; HEMOPHILIA A; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RECOMBINANT PROTEINS;

EID: 14644408150     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-004-1542-6     Document Type: Article

References (8)

1. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P (1988) Development of the human coagulation system in the healthy premature infant. Blood 72: 1651-1657
2. Chalmers EA (2004) Haemophilia and the newborn. Blood Rev 18: 85-92
3. Gale RF, Hird MF, Colvin BT (1998) Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia 4: 850-853
4. Giangrande PLF (2003) Pregnancy in women with inherited bleeding disorders. World Federation of Hemophilia, Montreal
5. Klinge J, Auberger K, Auerswald G, Brackmann HH, Mauz-Korholz C, Kreuz W (1999) Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 158[Suppl 3]: S162-S165
6. Kulkarni R, Lusher J (2001) Perinatal management of newborns with haemophilia. Br J Haematol 112: 264-274
7. Lusher J (2004) Is the incidence and prevalence of inhibitors greater with recombinant products? No. J Thromb Haemost 2: 863-865
8. Scharrer I, Bray GL, Neutzling O (1999) Incidence of inhibitors in haemophilia A patients - a review of recent studies of recombinant and plasma-derived factor VIII concentrates. Haemophilia 5: 145-154